Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERN
926
CALL
DELISTED
Cerner Corp
CERN
| $22.5M | 0.01% |
364,800
+7,200
| +2% | +$454K |
|
927
CALL
Oneok
OKE
$58.1B
| $22.5M | 0.01% |
437,500
-127,900
| -23% | -$6.05M |
|
928
CALL
Goodyear
GT
$1.73B
| $22.3M | 0.01% |
691,600
+451,200
| +188% | +$13.1M |
|
929
ICICI Bank
IBN
$107B
| $22.3M | 0.01% |
3,278,812
+524,730
| +19% | +$3.66M |
|
930
PUT
Autodesk
ADSK
$53.1B
| $22.2M | 0.01% |
307,600
-81,200
| -21% | -$5.12M |
|
931
CALL
Cardinal Health
CAH
$54.4B
| $22.2M | 0.01% |
285,800
-49,800
| -15% | -$4.02M |
|
932
Palo Alto Networks
PANW
$284B
| $22.2M | 0.01% |
836,298
-445,734
| -35% | -$10.2M |
|
933
CALL
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$717M
| $22.2M | 0.01% |
22,755
+20,590
| +951% | +$17M |
|
934
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$653M
| $22.2M | 0.01% |
6,365
-12,000
| -65% | -$58.5M |
|
935
CALL
Ashland
ASH
$3.33B
| $22.2M | 0.01% |
391,017
+205,217
| +110% | +$11.8M |
|
936
PUT
Agnico Eagle Mines
AEM
$109B
| $22.1M | 0.01% |
408,800
-164,700
| -29% | -$9.07M |
|
|
NAV
937
CALL
DELISTED
Navistar International
NAV
| $22.1M | 0.01% |
967,300
+32,700
| +3% | +$498K |
|
938
PUT
Thermo Fisher Scientific
TMO
$232B
| $22.1M | 0.01% |
139,100
+50,000
| +56% | +$7.7M |
|
939
Franklin US Core Dividend Tilt Index ETF
UDIV
$147M
| $22.1M | 0.01% |
844,112
-32,225
| -4% | -$852K |
|
940
Advanced Micro Devices
AMD
$780B
| $22.1M | 0.01% |
3,197,383
+920,255
| +40% | +$5.88M |
|
941
CALL
Diamondback Energy
FANG
$56.6B
| $22.1M | 0.01% |
228,800
-220,100
| -49% | -$20.3M |
|
|
WWAV
942
PUT
DELISTED
The WhiteWave Foods Company
WWAV
| $22.1M | 0.01% |
405,800
+193,100
| +91% | +$10.6M |
|
|
BNY
943
CALL
Bank of New York Mellon
BNY
$110B
| $22.1M | 0.01% |
553,500
+250,100
| +82% | +$9.99M |
|
944
PUT
Avis
CAR
$5.16B
| $22.1M | 0.01% |
644,700
-8,800
| -1% | -$319K |
|
945
PUT
J.M. Smucker
SJM
$13.3B
| $22M | 0.01% |
162,600
+135,000
| +489% | +$19.8M |
|
946
PUT
Aflac
AFL
$58.9B
| $22M | 0.01% |
611,800
-20,800
| -3% | -$757K |
|
|
ALXN
947
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $22M | 0.01% |
179,400
-152,600
| -46% | -$19.6M |
|
948
PUT
Vertex Pharmaceuticals
VRTX
$140B
| $21.9M | 0.01% |
251,100
+24,400
| +11% | +$2.31M |
|
949
CALL
Automatic Data Processing
ADP
$112B
| $21.9M | 0.01% |
247,800
-65,800
| -21% | -$5.96M |
|
950
CALL
Dick's Sporting Goods
DKS
$12.2B
| $21.8M | 0.01% |
384,700
+254,400
| +195% | +$14M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.